Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5631]

Seeing double: Designing drugs that target “twin” cancer proteins

Seeing double: Designing drugs that target “twin” cancer proteins

Strategy to combat breast cancer involves two-pronged attack on enzyme that ‘feeds’ tumour

Strategy to combat breast cancer involves two-pronged attack on enzyme that ‘feeds’ tumour

New addition to standard-of-care treatments for non-small-cell lung cancer patients has potential to increase progression-free survival

New addition to standard-of-care treatments for non-small-cell lung cancer patients has potential to increase...

Online tool supports decisions about breast reconstruction after mastectomy

Online tool supports decisions about breast reconstruction after mastectomy

Programming cells to target brain tumours

Programming cells to target brain tumours

Metabolic reprogramming of T cells may enhance checkpoint inhibitor therapy

Metabolic reprogramming of T cells may enhance checkpoint inhibitor therapy

Non-invasive method to predict survival in patients with liver cancer

Non-invasive method to predict survival in patients with liver cancer

Up to one-third of antibody drugs are nonspecific, study shows

Up to one-third of antibody drugs are nonspecific, study shows

WCLC 2024: Dexamethasone reduces infusion-related reactions in patients with EGFR-mutated non-small cell lung cancer treated with intravenous amivantamab-vmjw

WCLC 2024: Dexamethasone reduces infusion-related reactions in patients with EGFR-mutated non-small cell lung...

New drug target discovered for aggressive form of prostate cancer

New drug target discovered for aggressive form of prostate cancer

More from ecancer